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Abstract: 
 
Schizotypy and schizophrenia involve disrupted context integration (CI), the ability to assimilate 
internal and external information into coherent mental representations. Research has primarily 
examined patients with schizophrenia, with fewer studies assessing CI in schizotypy-spectrum 
groups. The literature shows overall CI deficits, but mixed results for specific performance 
patterns and associations with clinical symptoms. Furthermore, conclusions are limited by small 
samples and heterogeneity across studies. To examine CI deficits across the schizotypy spectrum 
using AX-Continuous Performance Task (CPT) and Dot Pattern Expectancy task (DPX) 
performance. Systematic review involved searching 4 databases and 12 journals, examining key 
references, and contacting 227 researchers for published and unpublished data. Search terms 
included AX-CPT/DPX/dot pattern expectancy task/CNTRACs/context integration/context 
processing and schizo/prodromal/high risk/psychosis; context and ultra high risk. Independent 
data from studies with diagnostically or psychometrically assessed schizotypy-spectrum groups 
and AX-CPT/DPX tasks with 10+ trials and 60+% AX trials were included. Articles were 
independently coded by two authors using predefined coding schemes with good agreement. 
Meta-analyses pooled outcomes using random-effects models. Forty-one studies met inclusion 
criteria. CI impairment was present across the schizotypy spectrum. CI deficits in schizophrenia 
were substantial and associated with disorganized and negative symptoms. Outcomes were 
comparable between patients with chronic and first-episode schizophrenia. At-risk groups 
demonstrated moderate CI impairment. Results were robust across task parameters and there was 
no evidence that reporting biases grossly impacted outcomes. Findings lend support to theories 
suggesting that CI is a stable vulnerability factor for schizophrenia. 
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Article: 
 
General Scientific Summary—The current study found that patients with schizophrenia have 
trouble keeping goals in mind related to contextual settings and circumstances. People at risk 
to develop schizophrenia have similar difficulty, but to a lesser degree. These results reveal a 
promising way to detect people at risk for schizophrenia early on, even before other symptoms 
of the illness appear. 
 
Schizophrenia is the most severe manifestation of a continuum of symptoms and impairment 
known as schizotypy (e.g., Lenzenweger, 2010; Meehl, 1989). The schizotypy spectrum is 
heterogeneous and includes positive, negative, and disorganized dimensions. Positive schizotypy 
involves excesses and distortions in perception and thought content. Negative schizotypy 
involves diminished pleasure, social interest, thoughts, speech, affect, and motivation. 
Disorganized schizotypy involves impairment in the ability to regulate thoughts and actions, 
manifesting as odd speech and peculiar behavior (Kwapil & Barrantes-Vidal, 2015). 
 
Schizophrenia as a Disorder of Disrupted Context Integration 
 
Context integration (CI) is conceptualized as the adaptive, dynamic ability to assimilate internal 
information, such as task schemas, and external information, such as perceptual features of the 
environment, into a coherent mental representation (Barch et al., 2001, 2004; Cohen & Servan-
Schreiber, 1992). Disrupted CI is implicated in the development of schizotypy and 
schizophrenia, with theoretical connections dating back to early phenomenological descriptions: 
 
I only saw fragments: a few people, a kiosk, a house. To be quite correct, I cannot say 
that I see all of that, because the objects seemed altered from the usual. They did not 
stand together in an overall context, and I saw them as meaningless details. . . . My 
impressions did not flow as they normally do. (Matussek, 1987, p. 92) 
 
This account highlights the importance of context, which usually goes unnoticed but leaves a 
strange and fragmented world when disrupted. Early phenomenologists were influenced by 
Gestalt theory, which involves the tendency to perceive complete forms from individual visual 
elements (e.g., Wertheimer, 1912). Matussek (1952) and Conrad (1958) proposed that 
schizophrenic impairment in integrating individual stimuli within the perceptual context could 
contribute to delusion formation. This may occur as the dimming of the perceptual field causes 
stimuli to stand out, leading to attentional capture, feelings of uncertainty and anxiety, and 
ultimately, delusion as a means of restructuring the disorganized perceptual framework. 
 
Modern theories emphasize a neural basis for impaired CI in schizophrenia. CI is proposed to 
occur at globalized cellular and perceptual levels (e.g., Phillips & Singer, 1997). Impaired 
coordination between bottom-up and top-down processing of contextual information may be 
associated with symptoms of schizophrenia (e.g., Silverstein & Schenkel, 1997). Phillips and 
Silverstein (2013) reviewed information suggesting that widespread disruptions in coordination 
between nearby neurons and across longer-range brain regions have been found in schizophrenia, 
and that these processes are related to CI impairment. 
 
Impaired CI may not just be an outcome of schizophrenia, but may be an underlying mechanism 
contributing to cognitive, behavioral, and symptomatic manifestations of the illness (Barch & 
Braver, 2009; Cohen & Servan-Schreiber, 1992). CI is thought to underlie attention, working 
memory, and inhibition aspects of executive control. Thus, context representations serve as a 
top-down mechanism for focusing on task-relevant processes, and for maintaining and updating 
these representations over time (Barch & Braver, 2009; Barch & Sheffield, 2017). For example, 
poor representation and maintenance of context may manifest as behavioral symptoms such as 
disorganized speech resulting from failure to interpret a phrase’s meaning from the broader 
context of a sentence or conversation (Cohen & Servan-Schreiber, 1992). 
 
CI deficits are thought to involve impaired function in the dorsolateral prefrontal cortex 
(DLPFC) and its connection with other neural regions and neurotransmitter systems (see Barch 
& Sheffield, 2017). In line with these predictions, CI deficits are associated with diminished 
DLPFC activation and increased noise in the mesocortical dopamine system in empirical and 
computational studies (e.g., Barch et al., 2001; Braver, Barch, & Cohen, 1999; Lesh et al., 
2013; MacDonald & Carter, 2003). In sum, phenomenological and neuroscientific theories of 
schizophrenia posit a key role of disruptions in CI at behavioral and neurological levels. 
 
Measurement of Context Integration 
 
There are several ways to measure CI, including tools designed to assess perceptual organization, 
linguistic, and cognitive measures of context processing. However, it is unclear whether “CI” 
assessed using these different measures involves the same processes. Research on perceptual 
organization in schizotypy-spectrum psychopathology often draws on Gestalt principles, using 
illusions to assess automatic tendencies to integrate visual features into a holistic perception. For 
example, people with disorganized schizotypy are less influenced than control participants by 
visual illusions in which the illusory perception requires intact context processing (Uhlhaas, 
Silverstein, Phillips, & Lovell, 2004). Another line of research employs sentence completion 
tasks to assess use of linguistic context (e.g., Chapman, Chapman, & Daut, 1976). For example, 
patients with schizophrenia perform worse than controls on tasks requiring them to complete 
ambiguous sentences. Namely, they tend to provide the common use of words rather than the 
unique use of words prescribed by the context of the sentence (Bazin, Perruchet, Hardy-Bayle, & 
Feline, 2000). 
 
A third method for studying CI in schizophrenia uses cognitive tasks to measure ability to 
mentally maintain goals to guide behavioral responses to external stimuli (Barch & Braver, 
2009). There are a variety of cognitive tasks that measure constructs similar to CI; however, the 
term CI has been used so broadly that it becomes unclear to what extent these tasks tap the same 
construct. Therefore, the current meta-analysis took a focused approach to examine CI as 
narrowly defined above. The cognitive tasks determined to best fit this conceptualization of CI 
are the AX-Continuous Performance Task (CPT; Servan-Schreiber, Cohen, & Steingard, 1996) 
and its nonverbal analog, the Dot-Pattern Expectancy task (DPX; Jones, Sponheim, & 
MacDonald, 2010; MacDonald, Goghari, et al., 2005). These tasks were selected because (a) 
they show strong construct validity (Barch et al., 2009), (b) they map on to neural mechanisms 
implicated in CI (Braver et al., 1999), (c) their design allows for examination of a specific deficit 
in context processing—that is, greater impairment in CI compared with other areas of general 
cognition (Chapman & Chapman, 1973), (d) they have good psychometric properties, (e) there is 
a large body of literature using the tasks with schizophrenia-spectrum participants, (f) they were 
selected for inclusion in the Cognitive Neuroscience Test Reliability and Clinical Applications 
for Schizophrenia (CNTRACs) battery as cognitive neuroscience measures recommended for 
cross-cutting research in schizophrenia (Barch et al., 2009), and (g) synthesizing results from a 
single set of tasks ensures examination of a cohesive construct. Combining results from tasks 
assessing different cognitive processes could introduce noise to the data and lead to inconclusive 
or equivocal outcomes. 
 
Expert consensus from the Cognitive Neuroscience Treatment Research to Improve Cognition in 
Schizophrenia (CNTRICS) committee, which selected measures for the CNTRACs battery, was 
weighed heavily when considering tasks for the current meta-analysis. The CNTRICS committee 
chose the AX-CPT and DPX as the most appropriate measures of CI/goal maintenance. There 
are a number of similar tasks, such as probabilistic reversal learning, operation and symmetry 
span, preparing to overcome prepotency, and various Stroop tasks. However, these tasks were 
not selected as CI measures by the CNTRICS committee because they were deemed to lack 
construct validity, measure different aspects of executive control, are not widely used in 
schizophrenia research, or fail to differentiate specific cognitive impairment from generalized 
deficits (Barch et al., 2009; Carter, Minzenberg, West, & MacDonald, 2012). The present meta-
analysis followed the CNTRICS determination and focused on AX-CPT and DPX tasks. The 
measures not included in this review have merit and utility, but were not considered appropriate 
for inclusion in the current meta-analysis. 
 
The AX-CPT presents a series of single letters in rapid succession; an item pair is composed of 
two sequential letters, the cue followed by the probe. Participants must make a positive response 
when they see A followed by X (AX trials), and a negative response to other letter pairs: AY, 
BX, and BY, with B representing any non-A cue and Y representing any non-X probe. The AX-
CPT assesses mental representation and maintenance of context by including a high proportion 
of AX trials to create a prepotent bias toward positive response when task goals are maintained 
(Henderson et al., 2012; Servan-Schreiber et al., 1996). The most common version involves 70% 
AX, 10% AY, 10% BX, and 10% BY trials. Response patterns are used to compute an index of 
overall sensitivity: d′context = z(AXhits) − z(BXfalse alarms), with lower d′context reflecting 
worse CI. 
 
The DPX is a nonverbal variant of the AX-CPT that uses dot patterns instead of letters, which 
helps to minimize confounding verbal strategies. This variation sometimes involves a slightly 
different proportion of trial types (69% AX, 12.5% AY, 12.5% BX, and 6% BY trials). 
Performance on the AX-CPT and DPX correlate between .63 and .80 (Strauss et al., 2014), and 
both tasks demonstrate adequate internal consistency and test–retest reliability (Henderson et al., 
2012; Jones et al., 2010). 
 
A major benefit of the AX-CPT and DPX is that they allow researchers to examine a specific 
deficit in CI within a single task through examination of error patterns across trial types. 
Confirmatory factor analysis of both tasks showed that BX trials primarily load on a context-
processing factor, AY trials load on a preparatory factor, and AX trials load on both factors 
(MacDonald, Goghari, et al., 2005). BY trials check that participants understood and attended to 
the task. AY trials should be most difficult for individuals with intact CI who keep task goals in 
mind and prepare to respond when cued by A. BX trials should be most difficult for people with 
impaired CI because X triggers a response when the goal is not properly maintained (Barch & 
Braver, 2009). Two studies have shown a double-dissociation pattern, in which schizotypy-
spectrum groups made more errors than control groups on BX trials but fewer errors on AY trials 
(Barch et al., 2001; MacDonald, Pogue-Geile, Johnson, & Carter, 2003). 
 
 
Cue-probe delays can reveal processes related to maintenance of context. When CI is intact, BX 
accuracy should increase across longer delay periods because participants have more time to 
prepare a correct, nontarget response following the B-cue. In contrast, longer cue-probe delays 
should diminish AY accuracy in healthy participants because they have more time to prepare an 
incorrect, positive response to the A-cue. The opposite pattern is predicted for people with poor 
CI: longer cue-probe delays should yield lower BX and higher AY accuracy (Barch & Braver, 
2009; Stratta, Daneluzzo, Bustini, Prosperini, & Rossi, 2000). 
 
Review of CI Impairment in Schizotypy-Spectrum Psychopathology 
 
CI impairment has been proposed as a heritable vulnerability marker, or endophenotype, of 
schizophrenia (Barch, Carter, MacDonald, Braver, & Cohen, 2003; Gottesman & Gould, 2003). 
However, CI must be assessed premorbidly to distinguish risk from factors such as illness 
outcomes or medication effects. Findings of CI impairment in people with early onset 
schizophrenia and subclinical schizotypy would support CI as an endophenotype of the disorder. 
Published patient studies report CI deficits in terms of error patterns, RTs, and d′context 
comparing schizophrenia groups with healthy and psychiatric control groups (e.g., Barch et al., 
2003; Cohen, Barch, Carter, & Servan-Schreiber, 1999; Reilly et al., 2017). For example, 
patients with schizophrenia show diminished d′context compared with healthy controls on the 
AX-CPT and DPX (e.g., Barch et al., 2001; Henderson et al., 2012), with increased BX errors in 
patients, but variable results for other trial types. CI deficits are not unique to schizophrenia, 
although patients with schizophrenia generally demonstrate impairment that is more severe and 
stable than other psychiatric groups, such as other psychotic disorders or mood disorders 
(e.g., Barch et al., 2003; Cohen et al., 1999; Reilly et al., 2017; Richard, Carter, Cohen, & Cho, 
2013). 
 
Four studies examined CI in schizotypal personality disorder (SPD) using the AX-CPT or DPX 
and found greater BX relative to AY errors (Barch et al., 2004; McClure, Barch, Flory, Harvey, 
& Siever, 2008; McClure et al., 2007, 2010). Only one study has examined CI in clinical high-
risk participants, and reported more BX errors and lower d′context than healthy participants 
(Niendam et al., 2014). There is inconclusive evidence on CI impairment in unaffected relatives: 
some studies found small to large effects compared with healthy controls, whereas others found 
no group differences on BX errors or d′context (e.g., Delawalla, Csernansky, & Barch, 
2008; López-García et al., 2013; MacDonald, Goghari, et al., 2005; MacDonald et al., 
2003; Richard et al., 2013). Only one study examined AX-CPT performance in a subclinical 
group scoring high on schizotypy questionnaires (Sloat, 2007). Using two-tailed t tests, there 
were no differences in CI compared with healthy controls (our calculations from reported 
summary data; authors used one-tailed, focused contrasts to examine differences across multiple 
groups). In summary, CI deficits occur across the schizotypy spectrum in clinical and some at-
risk groups; however, mixed findings were common and there were few studies with unaffected 
relatives and subclinical schizotypy groups. 
 
Factors That May Influence CI Impairment 
 
Medications and illness duration can impact cognitive ability in schizophrenia. However, CI 
impairment is not likely attributable to medication effects because deficits are seen in 
medication-naïve patients (Barch et al., 2001). Indeed, CI impairment occurs in medicated and 
unmedicated patients compared with controls (e.g., Chung, Mathews, & Barch, 2011; Fornito, 
Yoon, Zalesky, Bullmore, & Carter, 2011; Lesh et al., 2015; Niendam et al., 2014; Richard et al., 
2013; Yoon et al., 2012). Patients with first-episode and chronic schizophrenia show substantial 
CI deficits on the AX-CPT and DPX compared with controls (e.g., Braver et al., 1999; Cohen et 
al., 1999; Lesh et al., 2013; Perlstein, Dixit, Carter, Noll, & Cohen, 2003; Stratta et al., 2000). 
Only one published study directly compared illness episodes: Servan-Schreiber et al. 
(1996) found that unmedicated, multiepisode patients had lower d′context than unmedicated, 
first-episode patients. Because research on illness duration is often confounded by medication 
status, both are important factors to consider when assessing CI. 
 
Associations of Schizotypy Spectrum Symptom Dimensions With CI 
 
Assessing schizotypy as a singular construct can lead to inconsistent, uninterpretable, and invalid 
findings (Kwapil & Chun, 2015); therefore it is important to examine CI in relation to schizotypy 
symptom dimensions. Disorganized symptoms have the strongest theoretical and empirical link 
with CI deficits. Disorganized symptoms are broadly associated with decreased activity in the 
DLPFC (Goghari, Sponheim, & MacDonald, 2010; Yoon et al., 2008) and with impairment in 
aspects of executive function (Nieuwenstein, Aleman, & de Haan, 2001). Cohen and colleagues 
(1999) proposed an association between CI and disorganized symptoms, especially formal 
thought disorder. There is considerable empirical support for the association of CI deficits and 
disorganized symptoms, with most studies showing significant associations along the schizotypy 
spectrum (e.g., Ceccherini-Nelli, Turpin-Crowther, & Crow, 2007; Jones et al., 2010; McClure et 
al., 2008; Richard et al., 2013; Sloat, 2007). 
 
Cohen and Servan-Schreiber (1992) proposed a link between negative symptoms and CI deficits. 
Negative symptoms are associated with diminished frontal and prefrontal cortex dopamine-
linked activity and executive functioning deficits (e.g., Andreasen, Flaum, Swayze, Tyrrell, & 
Arndt, 1990; Bora, Yucel, & Pantelis, 2009; Servan-Schreiber et al., 1996). Further, research in 
patients with schizophrenia indicates hypoactivation of the fronto-parietal network, which is 
implicated in cognitive control, in relation to task-based negative symptoms (poor reward 
learning; Culbreth, Gold, Cools, & Barch, 2016). There are theoretical and empirical bases for 
associations between negative symptoms and executive dysfunction, but compared with 
disorganized symptoms, there are less explicit theoretical connections between negative 
symptoms and CI. Associations of CI with negative symptoms have been demonstrated 
empirically, but less reliably than with disorganized symptoms. Patient studies show mixed 
results regarding negative symptoms and CI impairment (e.g., Barch et al., 2003; Javitt, 
Rabinowicz, Silipo, & Dias, 2007; MacDonald & Carter, 2003; Owoso et al., 2013; Stratta et al., 
2000). Further, associations with negative symptoms have not been supported across the 
schizotypy spectrum: null findings were reported in clinical high-risk, SPD, and subclinical 
schizotypy groups (McClure et al., 2008; Niendam et al., 2014; Sloat, 2007). 
 
Early phenomenologists described a connection between CI and delusions (Conrad, 
1958; Matussek, 1952). Others proposed that hallucinations represent a failure in source 
monitoring (Bentall, Baker, & Havers, 1991). Stratta and colleagues (2000) expanded upon this 
idea, suggesting that confusion between internal and external events in hallucinations may be 
associated with CI impairment given patients’ difficulty using the contextual network to 
determine the source of information. However, these models have not received strong empirical 
support: most studies using the AX-CPT and DPX found no associations between CI and 
positive symptoms (e.g., Gold et al., 2012; Javitt et al., 2007; McClure et al., 2008; Owoso et al., 
2013). Furthermore, one study reported that associations with positive symptoms were no longer 
significant after accounting for disorganized symptoms (Becker, 2012). 
 
Limitations of the Literature 
 
The literature on CI in schizophrenia is extensive, but results vary regarding error patterns, 
magnitude of effects, and association with clinical symptoms. Findings differ even within patient 
studies, but especially within at-risk studies. Overall, we know little about CI in subclinical 
schizotypy, particularly from a multidimensional perspective. The use of small samples and 
heterogeneous variables limits conclusions that can be drawn by qualitative review. Further, the 
potential for reporting bias, including file drawer effects, and use of the same participants across 
multiple publications inflates the perceived consistency of findings. Many of these shortcomings 
could be improved through use of systematic review and meta-analysis. Previous meta-analyses 
have included CPT tasks to assess factors such as cognitive remediation and executive function-
related brain abnormalities (e.g., Grynszpan et al., 2011; Minzenberg, Laird, Thelen, Carter, & 
Glahn, 2009). However, there are no comprehensive meta-analyses of AX-CPT and DPX 
performance; thus, this is the first known meta-analysis to assess CI deficits across the 
schizotypy spectrum using these tasks. 
 
Meta-analysis offers advantages over traditional narrative summaries, which may use imprecise 
search strategies, miss relevant research, gather information improperly, and fail to show overall 
magnitude of effects (Cooper, 2010; Higgins & Green, 2011). Meta-analysis can overcome 
random design flaws from primary studies and address reporting biases by obtaining unpublished 
data and applying corrective techniques. Thus, meta-analysis can determine the validity of 
synthesized results when drawn from an imperfect literature base. 
 
The goals of this project were to conduct a systematic review of the published and unpublished 
literature and use meta-analysis to examine CI using AX-CPT and DPX tasks along the 
schizotypy spectrum compared with healthy and psychiatric control groups, associations between 
CI and schizotypy symptom dimensions, and the impact of patient and task variables. Some task 
variables were assessed to examine CI theory (e.g., cue-probe delay should differentially impact 
groups), whereas other variables were assessed to help researchers select task parameters in 
future research (e.g., to understand how cue duration or number of trials impacts outcomes). 
 
Method 
 
Planning and a priori decisions were preregistered at Open Science Framework 
(https://osf.io/qhguz/) before analyses were conducted. Some researchers propose that meta-
analysis should represent an atheoretical examination of the available data (Charlton, 1996) 
whereas others believe hypotheses should be made whenever subgroup analyses are conducted 
(Sun, Briel, Walter, & Guyatt, 2010). Detailed hypotheses, including effect size predictions, 
were made but for the sake of space, the reader is referred to Open Science Framework for 
hypotheses and methodological and analytical decisions. 
 
Literature Search 
 
The following terms were used to search for English and non-English language articles in 
PsycINFO, PubMed, Google Scholar, and Scopus databases: AX-CPT/DPX/dot pattern 
expectancy task/CNTRACs/context* integration/context* processing and 
schizo*/prodromal/high risk/psychosis; context* and ultra high risk. In addition, searches were 
conducted in the following journals: Journal of Abnormal Psychology, Biological 
Psychology, Biological Psychiatry, Schizophrenia Research, Schizophrenia Bulletin, JAMA 
Psychiatry, Neuropsychology, American Journal of Psychiatry, Psychological Medicine, Journal 
of Clinical Neuropsychology, Psychiatry Research, and Schizophrenia Research: 
Cognition. References from key papers were examined and 227 researchers in the field were 
contacted for unpublished data. 42 researchers were contacted to obtain additional information 
from studies identified for inclusion. Records from 1986 on were systematically screened. 
Journal and database search was completed in February 2016, and contact of researchers was 
completed in June 2017. 
 
Inclusion Criteria for Studies and Participants 
 
The following inclusion criteria were defined a priori: (a) inclusion of participants with a 
diagnostic indicator or psychometric measurement of schizotypy-spectrum psychopathology; (b) 
use of an AX-CPT or DPX task with at least 10 trials, at least 60% AX trials, and no additional 
goals/parameters (e.g., ignoring background noise during the task). Studies or participant groups 
were excluded if data had reported or suspected overlap with another included study or if data 
were not reported separately for the schizotypy-spectrum group (e.g., studies combined data 
from participants with schizophrenia and mood disorders with psychotic features). First-degree 
relative groups were excluded when some participants had psychotic disorders. 
 
The first and second authors coded information. Discrepancies were discussed and resolved 
between coders. It was planned that the third author would consult in case of remaining 
disagreements. Researchers often used overlapping samples across articles, did not provide 
adequate descriptions of samples, or did not respond to communication; thus, unambiguous 
identification of sample overlap was not always possible. Because inclusion of multiple studies 
reporting the same data violates assumptions of independence and runs the risk of inflating 
conclusions, studies were excluded when overlap was suspected or verified. 
 
Analyses 
 
Data analysis followed best practices described by the PRISMA Guidelines (Liberati, Altman, 
Tetzlaff, et al., 2009; Moher, Liberati, Tetzlaff, Altman, The PRISMA Group, 2009), Cooper 
(2010), and Higgins and Green (2011). The PRISMA checklist (Moher et al., 2009) is included 
in the online supplemental material. A random-effects model was selected, which assumes that 
error may vary systematically across studies. Between-groups effects were converted to 
Hedges’ g and within-group effects were converted to Fisher’s z. Effect sizes from each study 
were weighted by inverse variance and summarized using Comprehensive Meta-Analysis 
Version 3 (Borenstein, Hedges, Higgins, & Rothstein, 2015). To estimate variance for each 
average effect size, 95% confidence intervals are presented in tables. Heterogeneity among 
effects was analyzed using Q, τ2, and I2 (Borenstein, 2009). For subgroup analysis, calculations 
were run with separate τ2 estimates for each subgroup. Alpha was set a priori at 0.05. 
 
Between-Group Analyses 
 
Healthy control comparisons. For comparisons between schizotypy-spectrum and healthy 
control groups, accuracy and d′context are reported across all trial types for short (<3500 ms) and 
long (>3500 ms) cue-probe delay. See Supplemental Table S1 for reaction time (RT) analyses. 
To limit the number of analyses, other between-groups analyses only examined key outcomes: 
AY errors, BX errors, and d′context. For symptom correlations, BX errors and d′context were 
assessed. Analyses were run separately for each variable to maintain independent data. 
Schizotypy-spectrum groups were compared with healthy controls for all trial types and 
d′context at short and long delay. 
 
Psychiatric control comparisons. Patients with schizophrenia were compared with psychiatric 
controls on AY errors, BX errors, and d′context collapsed across delay conditions. Magnitude of 
effects between patients with schizophrenia and healthy controls was compared with effects 
between at-risk participants and healthy controls for AY errors, BX errors and d′context 
collapsed across delay conditions. 
 
Subgroup analyses. Subgroup analyses compared magnitude of between-groups effects for 
patients with chronic schizophrenia, first-episode schizophrenia, and at-risk groups versus 
healthy controls for AY errors, BX errors, and d′context. 
 
Symptom-Task Correlations 
 
Within-group correlations of positive, negative, and disorganized symptoms with d′context and 
BX errors were synthesized in patients with schizophrenia. 
 
Moderation Analyses 
 
Moderation analyses examined whether AY error, BX error, and d′context effects for schizotypy-
spectrum groups compared with healthy controls were affected by categorical measures of cue 
duration (dichotomized at 500 ms) and cue-probe delay (dichotomized at 3500 ms). Task type 
was assessed as a moderator of AY errors, BX errors, and d′context; however, because of 
unequal distribution across diagnostic groups, task type analyses were only conducted for effects 
between patients with chronic schizophrenia and healthy controls. 
 
Meta-Regression 
 
Meta-regression assessed prediction of AY error, BX error, and d′context outcomes by 
continuous variables (Borenstein, 2009). Effects of schizotypy-spectrum groups versus healthy 
controls were regressed on cue-probe delay and number of trials. Effects of patients with 
schizophrenia versus healthy controls were regressed on patients’ length of illness. 
 
Reporting Biases 
 
Simonsohn’s p-curve, funnel plots, and the trim-and-fill method assessed asymmetry and skew in 
distribution of findings as estimations of publication bias and selective reporting. Simonsohn’s 
(2017)p-curve application Version 4.052 was used to detect p-hacking by plotting 
significant p values and examining the shape of the curve. This technique assumes that 
significant p values are more likely to be small than just under the 0.05 threshold. When the p-
curve is skewed to the right, evidential value is demonstrated, indicating effects are not solely 
due to p-hacking. Left skew suggests intensive p-hacking is likely present (Simonsohn, Nelson, 
& Simmons, 2014). Separate p-curves were plotted for correlations of positive, negative, and 
disorganized symptoms with BX errors and d′context at short and long delay. 
 
Funnel plots display an inverse graph of effect size on standard error. Ninety-five percent 
confidence intervals are displayed around the summary effect; when more than 5% of studies fall 
outside these intervals, it may indicate reporting bias, heterogeneity, or chance (Sterne et al., 
2011). Duval and Tweedie’s (2000) trim-and-fill method uses symmetry assumptions to estimate 
the number of “missing” studies, impute those values, and calculate an adjusted effect estimate. 
This method provides more conservative estimates if plot asymmetry is attributable to reporting 
bias. Plots were created for effects between schizotypy-spectrum groups and healthy controls, 
and between schizophrenia and psychiatric comparison groups for AY errors, BX errors, and 
d′context. 
 
Results 
 
Literature Search 
 
Figure 1 presents a diagram of search results, adapted from the PRISMA Guidelines (Moher et 
al., 2009). Forty-one independent studies were selected for inclusion in the meta-analyses 
(see Table 1). Overlapping samples across multiple publications was a major issue: 20 samples 
were excluded because of confirmed or likely reuse of participants. There was an 82% initial 
agreement rate between coders for 38 samples that were dual-coded (63% of included studies 
were dual-coded). Disagreements were resolved by consensus. 
 
Figure 1. Literature search results. Adapted from “Preferred reporting items for systematic 
reviews and meta-analyses: The PRISMA statement,” by D. Moher, A. Liberati, J. Tetzlaff, D. 
G. Altman, and the PRISMA Group, 2009, PLoS Medicine, 6, p. e1000097. Copyright 2009 by 
Public Library of Science. Adapted with permission. 
 
Table 1. Sample and Task Information for Studies Included in the Meta-Analysis 
Study Sample Task 
Barch et al. (2001) 14 first-episode schizophrenia 
12 healthy control 
AX-CPT 
Barch, Carter, MacDonald, Braver, and Cohen (2003) 49 first-episode schizophrenia 
30 non-schizophrenia psychotic control 
72 healthy control 
AX-CPT 
Barch et al. (2004) 26 SPD 
35 healthy control 
AX-CPT 
Barch, Yodkovik, Sypher-Locke, and Hanewinkel (2008) 57 chronic schizophrenia 
37 healthy control 
AX-CPT 
Becker (2012) 49 chronic schizophrenia 
28 healthy control 
AX-CPT 
Braver, Barch, and Cohen (1999) 16 first-episode schizophrenia 
16 healthy control 
AX-CPT 
Ceccherini-Nelli, Turpin-Crowther, and Crow (2007) 17 chronic schizophrenia 
14 non-schizophrenia psychotic control 
AX-CPT 
Study Sample Task 
15 depressed control 
16 healthy control 
Chung, Mathews, and Barch (2011) 41 chronic schizophrenia 
27 healthy control 
AX-CPT 
Cohen, Barch, Carter, and Servan-Schreiber (1999) 52 chronic schizophrenia 
25 depressed control 
31 healthy control 
AX-CPT 
Delawalla et al. (2006) 27 chronic schizophrenia 
31 relatives of schizophrenia 
81 healthy control 
AX-CPT 
Delawalla, Csernansky, and Barch (2008) 30 relatives of schizophrenia 
92 healthy control 
AX-CPT 
Dias, Bickel, Epstein, Sehatpour, and Javitt (2013) 17 chronic schizophrenia 
13 healthy control 
AX-CPT 
Edwards, Barch, and Braver (2010) 22 chronic schizophrenia 
14 healthy control 
AX-CPT 
Fisher (personal communication, 2016) 34 chronic schizophrenia AX-CPT 
Fornito, Yoon, Zalesky, Bullmore, and Carter (2011) 23 first-episode schizophrenia 
25 healthy control 
AX-CPT 
Gold et al. (2012); Henderson et al. (2012) 138 chronic schizophrenia 
136 healthy control 
DPX 
Holmes et al. (2005) 7 chronic schizophrenia 
10 depressed control 
9 healthy control 
AX-CPT 
Jones, Sponheim, and Macdonald (2010) 47 chronic schizophrenia 
48 healthy control 
DPX 
Lesh et al. (2015) 23 first-episode, medicated schizophrenia 
22 first-episode, unmedicated schizophrenia 
37 healthy control 
AX-CPT 
López-García et al. (2016) 15 chronic schizophrenia-spectrum 
16 relatives of schizophrenia 
20 healthy control 
DPX 
López-García, Young, Marín, Molero, and Ortuño (2015) 40 chronic schizophrenia-spectrum 
26 relatives of schizophrenia 
63 healthy control 
DPX 
MacDonald (2002) AX-CPT: 24 chronic schizophrenia, 24 
relatives of schizophrenia, 29 healthy 
control 
DPX: 17 chronic schizophrenia, 16 relatives 
of schizophrenia, 28 healthy control 
AX-CPT, DPX 
MacDonald and Carter (2003) 17 chronic schizophrenia 
17 healthy control 
AX-CPT 
McClure, Barch, Flory, Harvey, and Siever (2008) 63 SPD 
25 non-Cluster A personality disorder 
42 healthy control 
AX-CPT 
Merrill et al. (2017) 43 chronic schizophrenia 
19 healthy control 
AX-CPT 
Paavola (2013) 47 relatives of schizophrenia 
57 healthy control 
DPX 
Perlstein, Dixit, Carter, Noll, and Cohen (2003) 16 chronic schizophrenia 
15 healthy control 
AX-CPT 
Poppe, Carter, Minzenberg, and MacDonald (2015) 19 chronic schizophrenia 
33 relatives of schizophrenia 
50 healthy control 
AX-CPT 
Study Sample Task 
Poppe et al. (2016) 47 chronic schizophrenia 
56 healthy control 
DPX 
Reilly et al. (2017) 402 chronic schizophrenia 
304 bipolar with psychotic features 
210 healthy control 
DPX 
Richard, Carter, Cohen, and Cho (2013) 63 first-episode schizophrenia 
31 relatives of schizophrenia 
83 healthy control 
47 non-schizophrenia psychotic control 
AX-CPT 
Sheffield et al. (2014) 104 chronic schizophrenia 
132 healthy control 
AX-CPT, DPX 
Sheffield et al. (2015) 46 chronic schizophrenia 
54 healthy control 
DPX 
Sloat (2007) 25 psychometric schizotypy 
18 psychometric vulnerable to depression 
38 healthy control 
AX-CPT 
Stratta, Daneluzzo, Bustini, Prosperini, and Rossi (2000) 20 chronic schizophrenia 
20 healthy control 
AX-CPT 
Thoma and Daum (2008) 23 chronic schizophrenia 
22 depressed control 
20 healthy control 
AX-CPT 
Thoma, Zoppelt, Wiebel, and Daum (2007) 26 chronic schizophrenia 
13 healthy control 
AX-CPT 
Todd et al. (2014) 33 chronic schizophrenia 
58 healthy control 
AX-CPT 
Woodward (personal communication, 2016) 15 first-episode schizophrenia 
35 chronic schizophrenia 
19 bipolar with psychotic features 
39 healthy control 
AX-CPT 
Yoon et al. (2012) 51 first-episode schizophrenia 
51 healthy control 
AX-CPT 
Zhang et al. (2015) 339 chronic schizophrenia 
665 healthy control 
DPX 
 
Table 2 presents demographic information. Schizotypy-spectrum groups included patients with 
chronic and first-episode schizophrenia, people with SPD, unaffected relatives, and people with 
psychometrically identified schizotypy. Psychiatric comparison groups included people with 
nonschizophrenia psychosis, nonpsychotic depression, bipolar disorder, non-Cluster A 
personality disorders, and psychometrically identified risk for depression. As previously 
described, trial types included AX trials (context-processing and preparatory), BX trials (context-
processing), AY trials (preparatory), and BY trials (general cognition and attention; MacDonald, 
Goghari, et al., 2005). 
 
Between-Group Analyses 
 
Healthy control comparisons. Schizotypy-spectrum groups performed worse than healthy 
controls on almost every outcome (see Table 3). They made significantly more errors across all 
trial types for short delays, and across AX, BX, and BY trials for long delays. Schizotypy-
spectrum groups had significantly lower d′context for short and long delays. Very small (long 
delay) to small (short delay) effects were found for AY and BY errors. Medium effects were 
found for d′context (short delay) and AX and BX errors (short and long delay). A large effect 
was found for d′context at long delay. Significant heterogeneity was found across studies for all 
outcomes except short delay BX errors. 
 
Confidence intervals around effects were indirectly compared to infer differences across trial 
types. Indirect comparisons are observational and should be interpreted cautiously. For short 
delay, confidence intervals around AX errors overlapped slightly with those for AY and BY 
errors; confidence intervals for BX errors showed no overlap with AY and BY errors. For long 
delay, neither AX nor BX errors’ confidence intervals overlapped with those for AY and BY 
errors, suggesting that effects for CI-critical trials were larger than effects for trials tapping 
preparatory or general abilities. Overall, schizotypy-spectrum groups generally performed worse 
and error patterns were consistent with a specific deficit in CI. 
 
Psychiatric control comparisons. Patients with schizophrenia were compared with psychiatric 
controls. Table 4 presents AY error, BX error, and d′context results. Figure 2 presents a forest 
plot of d′context effects. The schizophrenia group had significantly lower d′context than the 
psychiatric control group at the level of a medium effect, with significant heterogeneity across 
studies. Patients with schizophrenia made significantly more BX errors than other psychiatric 
patients at the level of a small effect. Finally, there was no group difference in AY errors (very 
small effect). Heterogeneity across studies was not significant for AY and BX errors. In sum, CI 
was more impaired in schizophrenia than other psychiatric groups. 
 
 
Figure 2. Forest plot of d′context effects for schizophrenia versus psychiatric comparison 
groups. DEP = depressed controls; PSX = psychotic controls; FE = first-episode schizophrenia. 
The center of each white box represents Hedges’ g for single studies, the size of the box 
represents relative weight (inverse variance), and the bars represent 95% confidence intervals. 
Negative effects indicate the schizophrenia group performed worse than the psychiatric 
comparison group. The black diamond represents estimated Hedges’ g for the overall effect, with 
the width showing 95% confidence intervals. 
Table 2. Summary Demographic Information 
Variable First-episode, unmedicated First-episode, medicated Chronic schizophrenia At-risk group Healthy controls Psychiatric controls 
Age: M (SD) 23.70 (1.49) k = 5, n = 164 20.37 (.59) k = 4, n = 12 34.56 (4.89) k = 28, n = 2018 33.97 (9.60) k = 11, n = 364 30.47 (6.63) k = 40, n = 2659 33.37 (6.47) k = 12, n = 447 
Education (years): M (SD) 12.65 (.44) k = 5, n = 164 12.47 (.35) k = 4, n = 112 11.78 (1.71) k = 22, n = 1475 13.52 (1.17) k = 9, n = 323 12.93 (2.67) k = 33, n = 2186 13.76 (1.30) k = 7, n = 156 
Length of illness (years): M (SD) .58 k = 1, n = 22 .59 (.21) k = 2, n = 38 7.92 (4.27) k = 11, n = 849    
Female 30.07% k = 5, n = 164 26.84% k = 4, n = 112 35.81% k = 30, n = 2096 50.75% k = 11, n = 364 49.16% k = 39, n = 2639 53.97% k = 12, n = 447 
White  0% k = 1, n = 15 59.88% k = 11, n = 532 54.31% k = 6, n = 202 60.67% k = 15, n = 1181 69.86% k = 3, n = 259 
Black  80.00% k = 1, n = 15 43.22% k = 7, n = 783 43.42% k = 3, n = 108 27.98% k = 7, n = 527 21.15% k = 4, n = 284 
Latino  0% k = 1, n = 15 29.40% k = 4, n = 228 34.92% k = 4, n = 126 53.77% k = 4, n = 160 2.70% k = 2, n = 37 
Asian   50.75% k = 4, n = 1180 8.33% k = 3, n = 108 69.70% k = 3, n = 1066 3.3% k = 2, n = 240 
Other race/ethnicity  20.00% k = 1, n = 15 7.22% k = 3, n = 611 2.60% k = 2, n = 84 7.10% k = 3, n = 385 4.23% k = 3, n = 259 
% Medicated 0% k = 5, n = 164 78.22% k = 3, n = 61 99.71% k = 16, n = 1044    
Note. k = number of samples. n = number of participants. For categorical variables, numbers represent percentage within the subset of samples providing data for that category. 
 
Table 3. Schizotypy-Spectrum Versus Healthy Control Groups for Short and Long Cue-Probe Delay 
Measure k Hedges’ g Lower CI Upper CI p value Q df(Q) p value I2 τ2 
Short AX errors 21 .59 0.41 0.77 1.22E–10 51.59 20 1.31E–4 61.23 .095 
Short AY errors 22 .33 0.19 0.46 1.94E–6 33.59 21 .040 37.48 .036 
Short BX errors 22 .61 0.50 0.71 .00 22.22 21 .39 5.49 .0035 
Short BY errors 20 .32 0.14 0.50 6.48E–4 51.73 19 7.26E–5 63.27 0.99 
Short d’context 24 –.84 –1.06 –0.63 1.64E–14 96.00 23 6.84E–11 76.04 .20 
Long AX errors 25 .55 0.42 0.68 .00 38.35 24 .032 37.43 .033 
Long AY errors 26 .00 –0.17 0.18 .97 82.07 25 5.38E–8 69.54 .12 
Long BX errors 28 .59 0.47 0.72 .00 44.53 27 .018 39.36 .037 
Long BY errors 25 .19 –0.01 0.39 .06 100.39 24 2.57E–11 76.09 .17 
Long d’context 28 –.76 –0.91 –0.61 .00 67.11 27 2.87E–5 59.77 .08 
Note. k = number of samples; Hedges’ g: medium effects in bold, large effects in bold italics. 
 
Table 4. Schizophrenia Versus Psychiatric Comparison Groups 
 
Measure k Hedges’ g Lower CI Upper CI p value Q df(Q) p value I2 τ2 
AY errors 6 .02 –0.12 0.15 .81 1.95 5 .86 .00 .00 
BX errors 8 .33 0.19 0.46 1.65E–6 3.30 7 .86 .00 .00 
d’context 10 –.73 –1.07 –0.40 1.73E–5 36.38 9 3.39E–5 75.26 .19 
Note. k = number of samples; Hedges’ g: medium effects in bold. 
 
Subgroup analyses. Planned subgroup analyses were run dividing the schizotypy-spectrum 
group into individuals with schizophrenia and those at risk. Table 5 presents results and Figure 
3 presents a forest plot of d′context effects. The schizophrenia group had significantly lower 
d′context than healthy controls (large effect), more BX errors (medium effect), and more AY 
errors (small effect). Significant heterogeneity was observed across studies for all effects in the 
schizophrenia group. Compared with healthy controls, the at-risk group had significantly lower 
d′context and more BX errors (small effects). There were no group differences for AY errors 
(very small effect). Heterogeneity across studies was not significant in the at-risk group. 
 
Table 5. Diagnostic Subgroup Analyses 
Measure Subgroup k Hedges’ g Lower CI Upper CI Q df(Q) p value 
AY errors Schizophrenia 29 .29 0.16 0.42   1.79E–1 
 At-risk 8 –.04 –0.24 0.15   .66 
 Difference between subgroups     7.82 1 .0052 
BX errors Schizophrenia 32 .71 0.61 0.80   .0000 
 At-risk 9 .36 0.15 0.58   .0011 
 Difference between subgroups     8.14 1 .0043 
d’context Schizophrenia 28 –.94 –1.08 –0.80   .0000 
 At-risk 9 –.40 –0.56 –0.23   3.70E–6 
 Difference between subgroups     23.45 1 1.30E–6 
Note. k = number of samples; Hedges’ g: medium effects in bold, large effects in bold italics. Difference between 
subgroups involve indirect comparisons and should be interpreted cautiously. 
 
Indirect comparisons indicated that relative to healthy controls, the schizophrenia group had 
stronger effects than the at-risk group for AY errors, BX errors, and d′context. Significant 
unexplained variance remained after accounting for diagnostic status. Individuals with 
schizophrenia and those at risk showed CI deficits, and indirect comparisons suggested more 
pronounced deficits in patients. 
 
Planned comparisons examined patients with chronic schizophrenia (>1.5 years of illness), first-
episode schizophrenia (≤1.5 years of illness), and at-risk groups. Indirect comparisons indicated 
no difference in effect size between chronic and first-episode groups compared with controls 
(Supplemental Table S2). Length of illness was not associated with CI when examined 
categorically. 
 
Symptom-Task Correlations 
 
Correlations between symptom dimensions and task outcomes were examined in patients with 
schizophrenia (see Table 6). Disorganized symptoms showed significant associations with 
d′context and BX errors (small effects), with significant heterogeneity across studies. Negative 
symptoms were significantly correlated with d′context and BX errors (small effects). Positive 
symptoms were not associated with CI (very small effects). No significant heterogeneity across 
studies was observed for positive or negative symptom correlations. Indirect comparisons 
suggested that magnitude of effects did not differ among the three symptom dimensions. 
 
 
 
Figure 3. Forest plot of d′context effects for patients with schizophrenia and at-risk group versus 
healthy controls. FE = first-episode schizophrenia. Effects for schizophrenia on top and at-risk 
group on bottom. The center of each white box represents Hedges’ g for single studies, the size 
of the box represents relative weight (inverse variance), and the bars represent 95% confidence 
intervals. Negative effects indicate the schizotypy-spectrum group performed worse than the 
control group. Black squares represent estimated Hedges’ g for the overall subgroup effect, with 
the bars showing 95% confidence intervals. The black diamond represents the overall effect 
across subgroups, with the width showing 95% confidence intervals. 
 
 
 
 
Table 6. Symptom-Task Correlations in Schizophrenia Patients 
Symptoms Variable k Pearson’s r Lower CI Upper CI p value Q df(Q) p value I2 τ2 
Positive d’content 17 –.054 –0.12 0.012 .11 17.35 16 .36 7.77 .0015 
 BX errors 12 .049 –0.021 0.12 .17 10.98 11 .45 .00 .0000 
Negative d’content 17 –.15 –0.22 –0.069 .00 20.80 16 .19 23.07 .0055 
 BX errors 12 .12 0.017 0.21 .021 14.64 11 .20 24.87 .0068 
Disorganized d’content 14 –.22 –0.34 –0.094 .001 28.65 13 .0073 54.63 .029 
 BX errors 10 .24 0.070 0.39 .006 19.13 9 .024 52.96 .037 
 
Moderation Analyses 
 
Cue duration and cue-probe delay were assessed as categorical moderators of outcomes between 
schizotypy-spectrum and healthy control groups (Supplemental Tables S3 and S4). Cue duration 
and cue-probe delay moderated AY accuracy: long cues (≥1,000 ms) showed significantly 
stronger effects than short cues (<1,000 ms), and short delays (<3500 ms) showed significantly 
stronger effects than long delays (≥3500 ms). Neither cue duration nor cue-probe delay 
moderated effects for BX errors or d′context. 
 
Task type (AX-CPT vs. DPX) was assessed as a categorical moderator of outcomes between 
patients with chronic schizophrenia and healthy controls; there were insufficient DPX studies for 
analysis with other groups. Task type did not moderate effects for AY errors, BX errors, or 
d′context. Overall, schizotypy-spectrum CI deficits are robust across task parameters. 
 
Meta-Regression 
 
Number of trials and cue-probe delay were assessed as continuous predictors of outcomes 
between schizotypy-spectrum and healthy control groups. Figure 4 depicts number of trials 
regressed on d′context. Number of trials explained significant variance in d′context and AY 
errors: with more trials, studies showed weaker positive AY effects and stronger negative 
d′context effects (Supplemental Table S5). Number of trials did not predict BX error effects. 
Neither cue-probe delay nor patients’ length of illness predicted AY error, BX error, or d′context 
effects. 
 
Reporting Biases 
 
Funnel plots and the trim-and-fill method were employed for short and long delay AY errors, BX 
errors, and d′context in schizotypy-spectrum versus healthy control groups; AY errors, BX 
errors, and d′context scores collapsed across delay in schizophrenia versus psychiatric control 
groups; and correlations of positive, negative, and disorganized symptoms with short and long 
delay BX errors and d′context in schizophrenia. Zero to nine values were imputed per plot and 
none of the adjusted estimates differed significantly from observed estimates. p-curves were 
created for correlations of positive, negative, and disorganized symptoms with BX errors and 
d′context at short and long delay. None of the curves were significant for p-hacking. p-curves for 
disorganized and negative symptom correlations with d′context demonstrated evidential value. 
Other curves could not be generated or were inconclusive. 
 
Figure 4. Meta-regression of number of trials predicting Hedges’ g for d′context in schizotypy-
spectrum versus healthy control groups. Circles represent individual studies, with the size 
showing relative weight (inverse variance). 
 
Discussion 
 
Impaired CI has been proposed as a specific deficit in schizophrenia that presents before 
psychosis onset and may be implicated in the development of certain schizotypic symptoms. 
Numerous studies have used AX-CPT and DPX tasks to assess CI in patients with schizophrenia, 
but few have examined CI in nonpsychotic schizotypy. The literature is limited by use of small 
samples, varying task parameters, and heterogeneous patient characteristics that complicate 
interpretation of findings. Meta-analysis is particularly suitable for mitigating many of these 
limitations. The current study was the first comprehensive meta-analysis of CI impairment and 
the impact of relevant variables using the AX-CPT and DPX in the schizotypy-spectrum. The 
study expands upon the extant literature by including a comprehensive synthesis of published 
and unpublished data using these tasks, presenting conclusions from independent data, providing 
estimates of effect sizes across a large number of studies, and examining reporting biases. 
 
Summary of Findings 
 
Forty-one independent samples were included in the meta-analyses. Results supported CI 
impairment across the schizotypy spectrum, as measured by AX-CPT and DPX tasks. Deficits in 
patients with schizophrenia were substantial and stable across illness duration. At-risk groups 
showed milder CI disruption when indirectly compared with schizophrenia groups. Disorganized 
and negative symptoms were inversely correlated with CI, whereas positive symptoms were 
unassociated. Larger effects were found with more trials, but no other task parameters 
appreciably affected outcomes. Results did not differ using corrective methods to adjust effect 
estimates. Further, p-curve analyses showed no evidence that symptom correlations were solely 
attributable to p-hacking. Although reporting biases can never be ruled out, they did not grossly 
impact findings, supporting validity of the current results. 
 
Interpretation of Results 
 
Schizotypy-spectrum groups performed worse than healthy controls on most outcomes. 
However, schizotypy-spectrum errors on AX and BX trials were substantial and surpassed BY 
errors. AX and BX trials are thought to tap CI and BY trials roughly estimate generalized 
impairment (MacDonald, Goghari, et al., 2005). Thus, these differential effect sizes are 
consistent with a specific deficit in CI that extends beyond generalized deficits because of issues 
such as inattention and amotivation (Chapman & Chapman, 1973; MacDonald & Carter, 2002). 
 
Negligible to small effects were found for AY accuracy: schizotypy-spectrum groups made 
slightly more errors than healthy controls. AY errors are proposed to reflect intact CI because 
goal maintenance should create a positive response expectancy for A cues (Barch & Braver, 
2009; Henderson et al., 2012). However, MacDonald, Goghari, et al. (2005) suggested that 
elevated AY errors in schizophrenia may reflect poor response inhibition. A crossover effect—in 
which schizotypy-spectrum groups perform worse than controls on BX trials but better on AY 
trials—is theoretically compelling but has not received strong empirical support. Thus, it seems 
more likely that the BX-AY discrepancy constitutes a relative difference within schizotypy rather 
than an absolute difference between groups (e.g., Barch et al., 2004; Henderson et al., 2012). 
 
Consistent with CI theory (Cohen et al., 1999; MacDonald, Carter, et al., 2005), the current 
results indicated that CI deficits were more pronounced in patients with schizophrenia than other 
psychiatric groups, including non-schizophrenia psychosis. This indicates that CI may be 
specifically disrupted in schizophrenia beyond general psychiatric impairment. Indirect 
comparisons should be interpreted cautiously but suggest that individuals with schizophrenia 
likely have greater impairment than those at risk. In terms of unstandardized errors, patient and 
at-risk groups made about 4% more BX errors than healthy controls. People who have never 
experienced psychosis—and most likely never will—still show significant cognitive impairment. 
This supports theories that CI may be a precursor to schizophrenia, or even a mechanism 
influencing its development (Barch & Braver, 2009). 
 
Subgroup analyses revealed similar effects for chronic and first-episode patients, with both 
showing large CI deficits compared with healthy participants. These results were supported by 
meta-regression findings that illness duration did not predict outcomes. This is partially 
consistent with findings from a longitudinal study indicating that CI performance in first-episode 
patients was comparable between baseline and 1-year follow-up for short delay, but improved for 
long delay (Richard et al., 2013). Current results suggest that CI deficits may be stable 
throughout illness, although additional longitudinal studies are warranted. Given that CI is 
present premorbidly and at psychosis onset, persists throughout illness, and is not episode-
limited, it may be a stable vulnerability indicator for schizophrenia (Barch et al., 
2003; Nuechterlein et al., 1992). 
 
Chan and Gottesman (2008) proposed requirements for endophenotypic markers. Based on 
research to date, CI fulfills five of six criteria: CI deficits are associated with illness, state-
independent, present in unaffected family members, reliably measured, and show diagnostic 
specificity. Previous research indicated that DPX performance is influenced by the Val158Met 
COMT polymorphism, a gene associated with risk for schizophrenia (López-García, Young, 
Marín, Molero, & Ortuño, 2015; MacDonald, Carter, Flory, Ferrell, & Manuck, 2007). However, 
it is unclear whether CI impairment is more prevalent among affected versus unaffected relatives 
of schizophrenia probands. Investigating this final criterion is an important step if CI is to be 
established as an endophenotype, which would allow researchers to quickly and nonintrusively 
screen people purportedly at risk for schizophrenia. This could aid in identifying individuals for 
prophylactic intervention and investigating risk and protective variables implicated in the 
development of schizotypy-spectrum disorders. 
 
CI and schizotypy symptoms. Within schizophrenia groups, disorganized and negative 
symptoms were associated with impaired CI, whereas positive symptoms were not. The small 
effect sizes may, in part, reflect that assessment of CI across symptom dimensions was not a 
primary goal of most studies. The literature includes many correlations run in mixed symptom 
groups with varied representation and severity of each symptom dimension, using 
conceptualizations driven largely by measures rather than theory. We propose that future studies 
should be designed to assess symptom associations with CI in adequately powered samples, 
beginning with strong theoretical conceptualizations of dimensions, valid operationalization and 
measurement of symptoms, and recruitment of schizophrenia-spectrum groups with comparable 
representation of each symptom dimension. 
 
Despite the shortcomings of the literature, current findings indicate robust associations of 
disorganized and negative symptoms with CI. These differential associations are consistent with 
theories connecting neurocognitive impairment with disorganized and negative symptoms (Barch 
et al., 2001; Cohen et al., 1999; Goghari et al., 2010; Yoon et al., 2008). Neuroimaging studies 
have supported the association between CI and disorganized symptoms. For 
example, MacDonald, Carter, et al. (2005) showed that diminished prefrontal activity following 
B-cues was associated with greater BX errors in patients with schizophrenia and greater 
disorganized symptoms. Yoon et al. (2008) found that disorganized symptoms were related to 
decreased DLPFC activity and diminished connectivity to a broader neural network implicated in 
cognitive control. Poor top-down control may contribute to impaired CI and behavioral 
symptoms of disorganization (MacDonald, Carter, et al., 2005; Yoon et al., 2008). 
 
Early phenomenologists proposed connections between positive symptoms and disintegration of 
perception from the environmental context (Conrad, 1958; Matussek, 1952). This was not 
supported by the present meta-analysis: positive symptoms showed negligible associations with 
CI. There are gaps in understanding the integration of “context” across different levels of 
processing. It remains an empirical question whether performance on neurocognitive tasks would 
translate to behavioral manifestations of poorly integrated context described in the 
phenomenological literature. 
 
Moderating factors. Task type, cue duration, and cue-probe delay did not moderate effects 
between schizotypy-spectrum and healthy control groups for BX errors or d′context. The null 
delay findings are surprising given theories that CI performance should deteriorate more for 
schizotypy-spectrum groups than controls across longer delay periods (Barch & Braver, 2009). 
Results may suggest that performance deficits attributable to poor maintenance of context do not 
reliably manifest above and beyond those attributable to initial poor representation of context. 
However, it is possible that context maintenance effects would be revealed using longer delay 
periods. Authors aiming to distinguish representation and maintenance of context may consider 
cue-probe delays greater than 10 seconds, the maximum duration in the included studies. 
 
Because novel dot patterns in the DPX make cue maintenance more challenging than in the AX-
CPT (Barch et al., 2009), the DPX may be more sensitive to subtle deficits in at-risk individuals 
by avoiding possible ceiling effects. Although task type did not affect outcomes, analyses did not 
assess this in at-risk groups. Task type could only be examined as a moderator for outcomes 
between schizophrenia and healthy control groups because the DPX was used infrequently. 
Further study is needed to examine whether the DPX is a more appropriate measure of CI in less 
impaired individuals. Number of trials predicted group differences with more trials yielding 
stronger d′context effects, likely due to improved reliability. Overall, CI deficits were robust 
across task parameters. 
 
Limitations and Recommendations 
 
The current study reflects limitations in the literature, especially inability to examine medication 
effects. Too few studies (k = 3) examined medicated, first-episode patients to provide adequate 
power for subgroup analysis. Most patients with chronic schizophrenia in the literature were 
medicated and in nonacute phases of illness. Further research is needed to examine the impact of 
medication and distinguish illness duration from medication status. Few studies have tackled 
these issues. Using a cross-sectional design, Lesh et al. (2015) found that unmedicated first-
episode patients had worse CI than medicated first-episode patients at the level of a medium 
effect. In preliminary cross-sectional results from Woodward (personal communication, 
2016; Giraldo-Chica, Rogers, Damon, Landman, & Woodward, 2018), medicated first-episode 
patients (n = 15) had worse CI than medicated chronic patients (n = 35) at the level of a small 
effect. Finally, Barch and colleagues’ (2003) longitudinal design showed that first-episode 
patients had comparable CI performance when medication-naïve and following antipsychotic 
treatment four weeks later. Overall, it remains unclear how medications and illness progression 
impact CI. Research directly comparing medicated and unmedicated chronic patients with 
medicated and unmedicated first-episode patients could help clarify these relationships. 
Additionally, it could be helpful to differentiate among patients who are medication-naïve, 
medication noncompliant, and so forth 
 
Cognitive impairment often predicts functional outcome in schizophrenia, thus it would be 
beneficial to understand how CI deficits influence functioning and quality of life in social and 
occupational settings. These relationships could not be assessed in this meta-analysis because too 
few studies reported associations with functional outcome. Those that did generally found 
correlations of CI with global and community functioning, and performance-based skills in 
patients with schizophrenia, with effects ranging from negligible to large (Gold et al., 
2012; Richard et al., 2013; Sheffield et al., 2014; Stratta et al., 2000; Todd et al., 2014). Given 
their applicability to intervention, further assessment of CI and functional outcome is warranted. 
 
Inclusion of participants in multiple publications was widespread, and overlap in samples was 
not always clearly described. There were instances in which CI data for more than half the 
sample were previously published. Ethical issues aside, this practice is problematic because it 
inflates perceived reliability of findings in qualitative reviews and hinders data synthesis in 
quantitative reviews. If researchers reuse data across publications, it is recommended that they 
acknowledge this and provide subset analyses with new participants to distinguish which data are 
novel. 
 
There was significant heterogeneity across studies in many of the current meta-analyses. The 
diagnostic and parametric variables used to predict CI outcomes did not fully account for 
variability in performance, suggesting that there is still much to learn about what impacts CI. We 
proposed some variables that may contribute to heterogeneity, such as unexamined medication 
effects and poorly measured variation in symptoms, but we cannot rule out that other 
confounding factors influenced results (e.g., educational background, socioeconomic status). 
 
Finally, the term CI has been used extensively in the clinical literature and there are numerous 
neurocognitive tasks that assess similar constructs. The current meta-analysis took a focused 
approach by including two tasks that were determined to best capture CI as defined in this paper; 
however, it is unclear whether conclusions about CI impairment as measured by AX-CPT and 
DPX would generalize to other measures purportedly assessing “CI.” 
 
Summary and Conclusions 
 
CI impairments measured with AX-CPT and DPX tasks appear to be present across the 
schizotypy spectrum and occur in premorbid, active, and residual phases of schizophrenia. Thus, 
CI is not simply an episode marker or consequence of the catastrophic effects of schizophrenia. 
CI is associated with disorganized and negative symptoms of schizophrenia and appears stable 
throughout the course of illness. Current results support theories that CI may be a stable 
vulnerability factor for schizophrenia. Further study is warranted to confirm whether CI is an 
endophenotype, clarify its role in schizotypy-spectrum symptoms and impairment, and determine 
whether deficits can be remediated. Recommendations for future research include focus on 
longitudinal studies, at-risk samples, research designed to differentiate effects of medication and 
duration of illness or number of illness episodes, research designed to assess associations of 
symptom dimensions with CI, and examination of the relationship between CI and functioning. 
 
The implication of CI in the development and expression of schizotypy-spectrum 
psychopathology has roots in phenomenological, neural, and cognitive neuroscience theories. 
Foundational research in this area has established a strong basis for CI impairment that is linked 
to cognitive and neurological outcomes. Important next steps include developing a nuanced 
understanding of how specific factors may interact to influence CI in schizotypy and integrating 
this research across fields of study for a more holistic understanding of the mechanisms at play. 
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